Synergy Disc vs. ACDF Surgery for Degenerative Disc Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the Synergy Disc, a new device designed to help individuals with degenerative disc disease (DDD) in their necks by restoring movement and reducing pain. The trial aims to demonstrate that the Synergy Disc is as safe and effective as the traditional surgery method known as ACDF. Suitable candidates for this trial have experienced severe neck and arm pain due to DDD at two neck levels, have not found relief with other treatments, and have issues like nerve or spinal cord compression. Researchers will monitor participants from before surgery up to two years after to evaluate the device's effectiveness. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance future treatment options for DDD.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you cannot participate if you have taken drugs that interfere with bone metabolism, like steroids or methotrexate, within two weeks before surgery, or if you need medications that affect implant stability after surgery.
What prior data suggests that the Synergy Disc is safe for treating cervical degenerative disc disease?
Research has shown that the Synergy Disc, a device used in the neck, is under evaluation for safety and effectiveness in treating spinal wear-and-tear. Some studies compare its performance to traditional surgical methods like anterior cervical discectomy and fusion (ACDF).
The Synergy Disc aims to improve spinal movement post-surgery. Although detailed safety information is not yet available, the trial's progression suggests early results were likely positive. Complete safety information will become available once current and future studies conclude.12345Why are researchers excited about this trial?
Researchers are excited about the Synergy Disc because it offers a fresh approach to treating degenerative disc disease in the cervical spine. Unlike the standard treatment, Anterior Cervical Discectomy and Fusion (ACDF), which limits movement by fusing the spine, the Synergy Disc is a prosthetic disc designed to restore natural motion. This innovative device is placed between the vertebrae and helps maintain spinal kinematics, potentially reducing the wear and tear on adjacent discs. By focusing on motion preservation, the Synergy Disc could lead to better long-term outcomes for patients with intractable radiculopathy and myelopathy after discectomy.
What evidence suggests that the Synergy Disc is effective for treating cervical degenerative disc disease?
This trial will compare the Synergy Disc with ACDF surgery for treating degenerative disc disease. Research shows that the Synergy Disc is designed to improve neck movement after surgery on two levels of the neck. It aims to match the safety and effectiveness of the traditional ACDF surgery, commonly used for worn-out neck discs. Studies have found that using a cervical artificial disc like the Synergy Disc can maintain more natural neck movement compared to fusion surgery. This approach might also reduce the likelihood of needing additional surgeries. Early results suggest that the Synergy Disc could be a promising option for individuals with persistent neck pain or nerve issues unresponsive to other treatments.12367
Who Is on the Research Team?
Josh Butters, ME, MBA
Principal Investigator
Synergy Spine Solutions
Are You a Good Fit for This Trial?
This trial is for adults over 18 with neck pain and cervical degenerative disc disease at two adjacent levels from C3 to C7, who haven't improved with non-surgical treatments. They must have a specific level of disability and pain, documented nerve compression, no severe facet joint issues or certain metabolic disorders, no recent investigational therapy or spinal surgeries (with some exceptions), not be pregnant or planning pregnancy during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Evaluation
Patients are evaluated preoperatively to assess baseline conditions and eligibility for surgery
Surgery
Participants undergo surgery for the insertion of the Synergy Disc or conventional ACDF
Post-operative Follow-up
Participants are monitored at 6 weeks, and 3, 6, 12, and 24 months after surgery for safety and effectiveness
Annual Follow-up
Follow-up continues annually until the last patient reaches 24-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Synergy Disc
Find a Clinic Near You
Who Is Running the Clinical Trial?
Synergy Spine Solutions
Lead Sponsor
MCRA
Industry Sponsor